Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review.
about
Stem cell treatment for acute myocardial infarctionStem cell therapy for chronic ischaemic heart disease and congestive heart failureStem cell treatment for acute myocardial infarctionStem cell therapy for ischaemic heart disease and congestive heart failureImpact of Timing following Acute Myocardial Infarction on Efficacy and Safety of Bone Marrow Stem Cells Therapy: A Network Meta-AnalysisHow to Improve the Survival of Transplanted Mesenchymal Stem Cell in Ischemic Heart?Priming the Surface of Orthopedic Implants for Osteoblast Attachment in Bone Tissue EngineeringEndpoints in stem cell trials in ischemic heart failureGene and cell therapies for the failing heart to prevent sudden arrhythmic deathImpact of intracoronary bone marrow cell therapy on left ventricular function in the setting of ST-segment elevation myocardial infarction: a collaborative meta-analysisBone marrow mononuclear cells and acute myocardial infarctionPotential of cardiac stem/progenitor cells and induced pluripotent stem cells for cardiac repair in ischaemic heart diseasec-kitpos GATA-4 high rat cardiac stem cells foster adult cardiomyocyte survival through IGF-1 paracrine signallingAdult Bone Marrow Cell Therapy for Ischemic Heart Disease: Evidence and Insights From Randomized Controlled TrialsThe stuttering progress of cell therapy for heart diseaseFifteen years of bone marrow mononuclear cell therapy in acute myocardial infarctionDirect reprogramming of mouse fibroblasts to cardiomyocyte-like cells using Yamanaka factors on engineered poly(ethylene glycol) (PEG) hydrogelsInjectable hydrogel as stem cell scaffolds from the thermosensitive terpolymer of NIPAAm/AAc/HEMAPCLTowards an advanced therapy medicinal product based on mesenchymal stromal cells isolated from the umbilical cord tissue: quality and safety data.Cardiac repair with adult bone marrow-derived cells: the clinical evidence.Route of delivery and baseline left ventricular ejection fraction, key factors of bone-marrow-derived cell therapy for ischaemic heart disease.Lasers, stem cells, and COPD.Circulating endothelial progenitor cells: a new approach to anti-aging medicine?Efficacy and safety of intracoronary autologous bone marrow-derived cell transplantation in patients with acute myocardial infarction: insights from randomized controlled trials with 12 or more months follow-up.Predictors of ventricular remodelling in patients with reperfused acute myocardial infarction and left ventricular dysfunction candidates for bone marrow cell therapy: insights from the BONAMI trial.Results of a phase 1, randomized, double-blind, placebo-controlled trial of bone marrow mononuclear stem cell administration in patients following ST-elevation myocardial infarction.Cell-based therapy for heart disease: a clinically oriented perspectiveIncidence of ventricular arrhythmias after stem cell therapy in patients with Chagas cardiomyopathy.Difference in mobilization of progenitor cells after myocardial infarction in smoking versus non-smoking patients: insights from the BONAMI trial.Myocardial transfection of hypoxia-inducible factor-1α and co-transplantation of mesenchymal stem cells enhance cardiac repair in rats with experimental myocardial infarction.Human umbilical cord tissue-derived mesenchymal stromal cells attenuate remodeling after myocardial infarction by proangiogenic, antiapoptotic, and endogenous cell-activation mechanismsReview article: current status of myocardial regeneration: new cell sources and new strategies.Intracoronary autologous mononucleated bone marrow cell infusion for acute myocardial infarction: results of the randomized multicenter BONAMI trialImplementation of cardovascular cell therapy network trials: challenges, innovation and lessons learned from experience in the CCTRNIntramyocardial transplantation of cardiac telocytes decreases myocardial infarction and improves post-infarcted cardiac function in rats.The neural stem/progenitor cell marker nestin is expressed in proliferative endothelial cells, but not in mature vasculature.Additive value of adult bone-marrow-derived cell transplantation to conventional revascularization in chronic ischemic heart disease: a systemic review and meta-analysis.Enhanced potency of cell-based therapy for ischemic tissue repair using an injectable bioactive epitope presenting nanofiber support matrixCardiosphere-derived cells improve function in the infarcted rat heart for at least 16 weeks--an MRI study.Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial.
P2860
Q24186920-AA5D65BE-1CC4-4FAA-B4AD-C83A3D2A350EQ24194988-FBE61F11-8009-422E-B24E-C14E3518646BQ24203736-04DCDFF2-B8C2-4C33-B244-A2C4D1ADB39DQ24240357-DF4AE77C-F861-4C8E-AEE4-56794964C50FQ26771257-3FC301E1-B024-4993-A166-D149FD86F0FEQ26774939-53FE2DCE-D5AD-4CA9-AD98-BD7BF0F6A57DQ26782465-830984C8-A937-47E2-B7EF-785CC7D87C03Q26796330-239EFD76-CC39-4669-B4EB-418CB29EF0C5Q26865425-52A217D6-C89C-429F-A3A0-8462FB76E194Q27001633-E55A4A37-10A7-4DEE-A613-7F73B851D89EQ27006710-CA59E0DA-5E33-4609-AC61-21E9BE208821Q27012551-28B6904F-3B10-4D01-A5FB-BE8C8FEB29ACQ27315833-430A4433-1D88-4EFA-8CC4-F94BA1FAF29BQ28082162-844DBC72-B626-4813-B221-0DA101BB9D4DQ28247457-26B5EBA0-64C4-43D1-B5EA-AB1A998BABE1Q29994502-E49C6EAF-ECDE-4465-9EB2-71C612F79149Q30541092-7CAC7066-C59E-4E7D-AC5F-4D5A93DE958DQ30571628-2B025891-7C60-4CCB-B9A1-3483E3CD729FQ30736517-7695D361-92BF-4F92-A103-56606B83B042Q33406980-3FB54083-69BA-4DC9-A7A5-731F42A4FDB6Q33490304-EDCE8F61-5223-4CE7-A00E-02A43BD256A8Q33531541-9BABB32C-12E6-40BA-90D0-C00C7A154D35Q33582866-2E86627C-B21B-4D15-924B-CADC59B9553AQ33607929-C357B992-65C6-46DC-B44A-33440E2BD0F1Q33661061-00BB4141-B747-4D8C-A450-7ACAE63C9FFEQ33687920-117E6064-B463-4CC3-B6A3-F647AAA1E445Q33713519-A9B8ED11-EA47-4E06-862D-D2FA1D1987C5Q33733431-315F9BDC-1A79-453A-AD21-6FFB0044B857Q33745962-F4544EF9-8458-4C0E-9011-28EDC2CA29BDQ33746524-25185477-A4A4-41E1-94AA-72544ED1BC7DQ33746675-FC210148-BB53-4432-929C-F6392311ED2FQ33753657-4D9CD176-4158-4AD0-8111-264A8EEE721BQ33762062-673D1901-7804-480E-A6AC-539703E0B6A0Q33981146-69868508-0670-418D-9FC7-4AA367F391D4Q33991604-CBE17608-6235-4450-AB41-0204CC9EBBE0Q34008284-8E11FA87-59AD-4C81-8CBD-E71CE27F2593Q34043802-C240AFA9-A38F-4253-9D23-F376F977E917Q34055868-BF356561-734A-4580-9F6B-60E07763DAE9Q34063589-A68C8B4B-B547-44CE-8BB6-4392CF172F8DQ34074673-5C8B3D75-556F-4C8D-B7F5-3F2D727A70CB
P2860
Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Autologous bone marrow stem ce ...... farction: a systematic review.
@ast
Autologous bone marrow stem ce ...... farction: a systematic review.
@en
type
label
Autologous bone marrow stem ce ...... farction: a systematic review.
@ast
Autologous bone marrow stem ce ...... farction: a systematic review.
@en
prefLabel
Autologous bone marrow stem ce ...... farction: a systematic review.
@ast
Autologous bone marrow stem ce ...... farction: a systematic review.
@en
P2093
P2860
P356
P1476
Autologous bone marrow stem ce ...... farction: a systematic review.
@en
P2093
Anthony Mathur
Chris J Hyde
Enca Martin-Rendon
Simon J Stanworth
Susan J Brunskill
Suzanne M Watt
P2860
P304
P356
10.1093/EURHEARTJ/EHN220
P577
2008-06-03T00:00:00Z